Financial Highlight / Main Financial Index

• Overview of Financial Results
• Financial Highlight
• Main Financial Index
• Financial forecast （full year plan）

During the first six months of the current fiscal year (May 1, 2025 to October 31, 2025), the Japanese economy recovered gradually along with an improvement in the employment and income environment. However, conditions remain uncertain due to the risk of downward pressure on the domestic economy from slowing conditions overseas, as well as rising prices, trends in trade policy and fluctuations in financial and capital markets.

Against this backdrop, in March 2025, the AIN HOLDINGS Group (the Group) announced its medium-to-long-term vision, “Ambitious Goals 2034: A decade to promote innovation and strive for our challenging goal of a trillion yen in sales.” To ensure medium-to-long-term corporate growth even in a rapidly changing market environment, we have established business-specific visions and aim to achieve net sales of ¥1 trillion, a net profit margin of 4.0%, and an ROE of 15.0% for the fiscal year ending April 2034.

In its sustainability management, the Group worked to provide healthcare and retail services in line with its mission to “contribute to local healthcare” and “provide beauty and happiness” – two of the Group’s materiality issues. During the first six months of the fiscal year, we conducted healthcare and health awareness activities for local communities, such as cooperating in awareness campaigns for “Japan Heart Day 2025,” co-sponsored by four organizations including the Japan Heart Foundation, and supporting initiatives by the Japan Sports Agency to improve life performance.

In recognition of these and other ongoing initiatives, the Company has been selected as a constituent of the following ESG indices for Japanese equities adopted by the Government Pension Investment Fund (GPIF), the world's largest pension fund: the FTSE Blossom Japan Sector Relative Index, the MSCI Nihonkabu ESG Select Leaders Index, the MSCI Japan Empowering Women Index (WIN), the S&P/JPX Carbon Efficient Index, and the Morningstar Japan ex-REIT Gender Diversity Tilt Index.

In the whole company, net sales net sales reached ¥299,857 million, increased 39.6% YoY and decreased 0.1% against the plan due to the consolidation of Sakura Pharmacy Group. Ordinary profit reached ¥9,913 million, increased 56.4% YoY and 10.1% against the plan.

In the dispensing pharmacy business, net sales reached ¥254,739 million, increased 36.6% YoY and 0.6% against the plan because the number of prescriptions at existing stores and stores opened in the previous year remained steady, and due to the consolidation of Sakura Pharmacy Group, etc. Segment profit reached ¥12,842 million, increased 33.1% YoY and 9.5% against the plan.

In the retail business, although Francfranc, which joined the group in previous fiscal year, contributed fully, net sales reached ¥39,568 million, increased 72.9% YoY and decreased 4.5% against the plan because both brands saw a decline in customer numbers due to persistently high temperatures since September. Segment profit reached ¥3,518 million, increased 107.7% YoY and decreased 7.9% against the plan.

（million yen）

（million yen）

（million yen）

（million yen）

（million yen）

（million yen）

Please refer to the following page for our financial forecast .